AIMT

Aimmune Therapeutics, Inc.
AIMT

Delisted

AIMT was delisted on the 12th of October, 2020.

96 hedge funds and large institutions have $757M invested in Aimmune Therapeutics, Inc. in 2017 Q2 according to their latest regulatory filings, with 13 funds opening new positions, 45 increasing their positions, 21 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
96
Holders Change
+6
Holders Change %
+6.67%
% of All Funds
2.4%
Holding in Top 10
5
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.12%
New
13
Increased
45
Reduced
21
Closed
7
Calls
$252K
Puts
Net Calls
+$252K
Net Calls Change
-$51K
Name Holding Trade Value Shares
Change
Shares
Change %
MAM
101
Meeder Asset Management
Ohio
-$3K -132 Closed